Skip to main content

Research Repository

Advanced Search

Patient factors associated with SSRI dose for depression treatment in general practice: A primary care cross sectional study

Johnson, Chris F; Dougall, Nadine J; Williams, Brian; MacGillivray, Stephen A; Buchanan, Alasdair I; Hassett, Richard D

Authors

Chris F Johnson

Brian Williams

Stephen A MacGillivray

Alasdair I Buchanan

Richard D Hassett



Abstract

Background
Antidepressant prescribing continues to rise. Increased long-term prescribing and higher doses are contributing to current growth; however, patient factors associated with the use of higher doses remain unknown. This study’s aim was to investigate patient factors associated with selective serotonin re-uptake inhibitor (SSRI) prescribed daily dose for depression treatment in general practice.
Methods
A stratified sample of low to high prescribing practices were selected. Routine individual patient-level data were extracted one practice at a time: September 2009 to January 2011. Patients included were ≥18 years, and prescribed an SSRI for depression. Logistic regression analysis was undertaken to assess individual predictor variables on SSRI daily dose by standard therapeutic dose versus higher dose, as SSRIs demonstrate flat dose response curves for depression treatment. Predictor variables included: age, gender, deprivation, co-morbidity, smoking status, being prescribed the same SSRI for ≥2 years, and patients’ general practice. For a subgroup of patients a second sub-group analysis included long-term benzodiazepine and/or z-hypnotic (B&Z) as a predictor variable.
Results
Inter-practice SSRI prescribing varied significantly; practice point prevalence ranged from 2.5% (94/3697) to 11.9% (359/3007) of the practice population ≥18 years old; median 7.3% (250/3421) (χ2 = 2277.2, df = 10, p 

Citation

Johnson, C. F., Dougall, N. J., Williams, B., MacGillivray, S. A., Buchanan, A. I., & Hassett, R. D. (2014). Patient factors associated with SSRI dose for depression treatment in general practice: A primary care cross sectional study. BMC Family Practice, 15(210), https://doi.org/10.1186/s12875-014-0210-9

Journal Article Type Article
Acceptance Date Dec 12, 2014
Online Publication Date Dec 24, 2014
Publication Date 2014-12
Deposit Date Mar 1, 2018
Publicly Available Date Mar 5, 2018
Journal BMC Family Practice
Print ISSN 1471-2296
Publisher BMC
Peer Reviewed Peer Reviewed
Volume 15
Issue 210
DOI https://doi.org/10.1186/s12875-014-0210-9
Keywords Family practice, chronic disease, depression, antidepressive agents, Benzodiazepines
Public URL http://researchrepository.napier.ac.uk/Output/837685
Contract Date Mar 5, 2018

Files

Patient factors associated with SSRI dose for depression treatment... (367 Kb)
PDF

Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/

Copyright Statement
© 2014 Johnson et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.









You might also like



Downloadable Citations